TB-500 for Post-Surgery Recovery: Protocol, Dosing, and What to Expect

What this protocol is for

TB-500 in post-surgery recovery is the systemic complement to BPC-157. Where BPC-157 supports the local wound environment (angiogenesis, fibroblast migration at the surgical site), TB-500 brings systemic cell migration and stem-cell mobilisation that reaches deeper structural layers: muscle, ligament, fascia, the broader vascular network that feeds the entire recovery process. The mechanism makes the recovery curve flatter and faster, particularly on procedures where the deeper tissue work (rotator cuff repair, ACL reconstruction, abdominal surgeries with fascial involvement) is the rate-limiting step.

The right window matters the same way it does for BPC-157. Most protocols start 1 to 2 weeks post-op once acute inflammation has settled and the surgical team has cleared tissue-support intervention. Adding TB-500 into the immediate post-op window without clearance is not a tactical move, it is risk. The mid-recovery window is where this peptide earns its place.

Anecdotally, users report TB-500 contributes most to the back end of the recovery curve, weeks 4 to 8 post-start, where the structural remodeling is happening. Research shows the mechanism is well characterised in animal models; human-translatable post-surgical trials are absent. Used by many in the recovery / biohacking space as the systemic half of the canonical post-op stack (BPC-157 plus TB-500). Confirm dose and timing with the operating surgical team before starting.

Dose for post-surgery recovery

2 to 2.5 mg subcutaneous twice weekly post-op. Loading at 5 mg per week for the first 4 weeks is common in more involved cases (tendon-to-bone procedures, multi-structure repairs). Drop to 2 to 2.5 mg weekly maintenance after loading. Abdominal subcutaneous is the systemic default.

Cycle length

4 to 8 weeks total, beginning 1 to 2 weeks post-op. Simple soft-tissue repairs at the shorter end. Complex reconstructions and tendon-to-bone procedures at the longer end with a full loading phase. Reassessment with the surgical team before extending past 8 weeks.

Stack pairings

Commonly stacked with BPC-157.

Expected timeline

Week 1–2 of TB-500 protocol (typically week 2–4 post-op): systemic exposure builds. Week 3–6 of protocol (week 4–8 post-op): structural remodeling phase, where the bigger functional gains land. Most hit physio milestones 1 to 3 weeks ahead of the surgical team's original timeline, particularly on the back-end work (return to running, lateral movement, full strength).

Common mistakes

• Starting TB-500 immediately post-op without clearance. The acute inflammatory phase has its own healing signal the surgical team is monitoring; uncleared intervention is risk.
• Running TB-500 without BPC-157 for surgery recovery. The canonical post-op stack is both compounds; alone, TB-500 underdelivers because the local wound work is BPC-157 strength.
• Skipping the loading phase on complex reconstructions. Tendon-to-bone and multi-structure repairs benefit from the front-loaded systemic push.
• Stopping at the moment the surgeon clears for full activity. The most important gains land in the last 2 to 3 weeks of the cycle when the deeper remodeling is finalising.